コンテンツへスキップ
Merck

13204

β-tri-Calcium phosphate

puriss. p.a., ≥98% β-phase basis (unsintered powder)

別名:

β-TCP, β-Tricalcium phosphate

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

実験式(ヒル表記法):
Ca3O8P2
CAS番号:
分子量:
310.18
UNSPSC Code:
12352302
PubChem Substance ID:
EC Number:
231-840-8
NACRES:
NA.55
MDL number:
Assay:
≥98% β-phase basis (unsintered powder)
Form:
powder
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


grade

puriss. p.a.

Quality Level

assay

≥98% β-phase basis (unsintered powder)

form

powder

impurities

≤250 mg/kg total sulfur (as SO4) (ICP), ≤50 mg/kg total heavy metals (as lead)

anion traces

chloride (Cl-): ≤100 mg/L

cation traces

As: ≤0.5 mg/kg, Ba: ≤10 mg/kg, Cd: ≤1 mg/kg, Co: ≤1 mg/kg, Cr: ≤5 mg/kg, Cu: ≤1 mg/kg, Hg: ≤0.5 mg/kg, Ni: ≤1 mg/kg, Pb: ≤5 mg/kg, Zn: ≤10 mg/kg

SMILES string

[Ca+2].[Ca+2].[Ca+2].[P](=O)([O-])([O-])[O-].[P](=O)([O-])([O-])[O-]

InChI

1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6

InChI key

QORWJWZARLRLPR-UHFFFAOYSA-H

General description

β-tri-Calcium phosphate belongs to the category of calcium-phosphate based ceramics, which has been involved in the preparation of a new biosynthetic material possessing morphogenetic activity that is used as a bone implant.

Analysis Note

Phase Composition (by XRD analysis)
Low crystalinity Hydroxylapatite at unsintered condition.
A high crystalinity β-Tricalcium phosphate after sintering at 1100C.
β-TCP: >98% (by x-ray diffraction analysis)
other Ca-P phases as Hydroxylapatite, a-TCP and Pyrophosphate <2.0%


Still not finding the right product?

Explore all of our products under


保管分類

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする



A new polyphosphate calcium material with morphogenetic activity
Muller.G.EW, et al.
Materials Letters, 148, 163-166 (2015)
Michael D Weiden et al.
PloS one, 9(10), e108476-e108476 (2014-10-02)
While exploring the effects of aerosol IFN-γ treatment in HIV-1/tuberculosis co-infected patients, we observed A to G mutations in HIV-1 envelope sequences derived from bronchoalveolar lavage (BAL) of aerosol IFN-γ-treated patients and induction of adenosine deaminase acting on RNA 1
S I Roohani-Esfahani et al.
Acta biomaterialia, 8(11), 4162-4172 (2012-07-31)
This is the first reported study to prepare highly porous baghdadite (Ca₃ZrSi₂O₉) scaffolds with and without surface modification and investigate their ability to repair critical-sized bone defects in a rabbit radius under normal load. The modification was carried out to